# Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke

> **NCT02235558** · PHASE1 · COMPLETED · sponsor: **Justin Fraser** · enrollment: 11 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Verapamil

## Key facts

- **NCT ID:** NCT02235558
- **Lead sponsor:** Justin Fraser
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-01
- **Primary completion:** 2016-03-21
- **Final completion:** 2016-03-21
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02235558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02235558, "Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02235558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*